https://www.selleckchem.com/pr....oducts/crenolanib-cp
However, advances in new and more sophisticated in vitro models of the PT, along with the application of high-content analytical methods that can provide readouts more relevant to the clinical manifestations of nephrotoxicity, are beginning to extend our knowledge. Such technical progress should help in discovering new biomarkers that can better detect nephrotoxicity earlier and predict its long-term consequences, and herald a new era of more personalized medicine. Dynamic contrast-enhanced ultrasound (DCE-US) was used to m
Like
Comment
Share
